Chemoembolization and Response-Dependent Resection
HCC_S012
Approved other active
Quick answer
Chemoembolization and Response-Dependent Resection for Resectable Hepatocellular Carcinoma Beyond Milan Criteria is a Approved program (other) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Resectable Hepatocellular Carcinoma Beyond Milan Criteria
- Phase
- Approved
- Modality
- other
- Status
- active